Literature DB >> 27638639

Assessment of non-linear combination effect terms for drug-drug interactions.

Gilbert Koch1,2, Johannes Schropp3, William J Jusko4.   

Abstract

Drugs interact with their targets in different ways. A diversity of modeling approaches exists to describe the combination effects of two drugs. We investigate several combination effect terms (CET) regarding their underlying mechanism based on drug-receptor binding kinetics, empirical and statistical summation principles and indirect response models. A list with properties is provided and the interrelationship of the CETs is analyzed. A method is presented to calculate the optimal drug concentration pair to produce the half-maximal combination effect. This work provides a comprehensive overview of typically applied CETs and should shed light into the question as to which CET is appropriate for application in pharmacokinetic/pharmacodynamic models to describe a specific drug-drug interaction mechanism.

Entities:  

Keywords:  Bliss Independence; Combination therapy; Drug–drug interaction; Loewe Additivity; Optimal concentration

Mesh:

Substances:

Year:  2016        PMID: 27638639      PMCID: PMC5439368          DOI: 10.1007/s10928-016-9490-0

Source DB:  PubMed          Journal:  J Pharmacokinet Pharmacodyn        ISSN: 1567-567X            Impact factor:   2.745


  38 in total

1.  Response surface model for anesthetic drug interactions.

Authors:  C F Minto; T W Schnider; T G Short; K M Gregg; A Gentilini; S L Shafer
Journal:  Anesthesiology       Date:  2000-06       Impact factor: 7.892

Review 2.  A MOLECULAR BASIS FOR DRUG ACTION.

Authors:  E J ARIUENS; A M SIMONIS
Journal:  J Pharm Pharmacol       Date:  1964-03       Impact factor: 3.765

3.  Affinity, intrinsic activity and drug interactions.

Authors:  E J ARIENS; J M VAN ROSSUM; A M SIMONIS
Journal:  Pharmacol Rev       Date:  1957-06       Impact factor: 25.468

4.  Kinetics of pharmacologic response. I. Proposed relationships between response and drug concentration in the intact animal and man.

Authors:  J G Wagner
Journal:  J Theor Biol       Date:  1968-08       Impact factor: 2.691

5.  PK-PD modeling of combination efficacy effect from administration of the MEK inhibitor GDC-0973 and PI3K inhibitor GDC-0941 in A2058 xenografts.

Authors:  Edna F Choo; Chee M Ng; Leanne Berry; Marcia Belvin; Nicholas Lewin-Koh; Mark Merchant; Laurent Salphati
Journal:  Cancer Chemother Pharmacol       Date:  2012-10-07       Impact factor: 3.333

6.  Pharmacodynamic model for joint exogenous and endogenous corticosteroid suppression of lymphocyte trafficking.

Authors:  M A Milad; E A Ludwig; S Anné; E Middleton; W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1994-12

7.  Pharmacodynamic modelling of the bispectral index response to propofol-based anaesthesia during general surgery in children.

Authors:  C Jeleazcov; H Ihmsen; J Schmidt; C Ammon; H Schwilden; J Schüttler; J Fechner
Journal:  Br J Anaesth       Date:  2008-02-12       Impact factor: 9.166

8.  Preclinical pharmacokinetic/pharmacodynamic models to predict schedule-dependent interaction between erlotinib and gemcitabine.

Authors:  Mengyao Li; Hanqing Li; Xiaoliang Cheng; Xipei Wang; Liang Li; Tianyan Zhou; Wei Lu
Journal:  Pharm Res       Date:  2013-01-24       Impact factor: 4.200

9.  Methods of solving rapid binding target-mediated drug disposition model for two drugs competing for the same receptor.

Authors:  Xiaoyu Yan; Yang Chen; Wojciech Krzyzanski
Journal:  J Pharmacokinet Pharmacodyn       Date:  2012-08-29       Impact factor: 2.745

10.  BRAID: A Unifying Paradigm for the Analysis of Combined Drug Action.

Authors:  Nathaniel R Twarog; Elizabeth Stewart; Courtney Vowell Hammill; Anang A Shelat
Journal:  Sci Rep       Date:  2016-05-10       Impact factor: 4.379

View more
  12 in total

1.  Quantitative systems pharmacology analysis of drug combination and scaling to humans: the interaction between noradrenaline and vasopressin in vasoconstriction.

Authors:  Anyue Yin; Akihiro Yamada; Wiro B Stam; Johan G C van Hasselt; Piet H van der Graaf
Journal:  Br J Pharmacol       Date:  2018-07-10       Impact factor: 8.739

2.  Assessment of Three-Drug Combination Pharmacodynamic Interactions in Pancreatic Cancer Cells.

Authors:  Emilie A G Molins; William J Jusko
Journal:  AAPS J       Date:  2018-06-27       Impact factor: 4.009

3.  Target mediated drug disposition with drug-drug interaction, Part II: competitive and uncompetitive cases.

Authors:  Gilbert Koch; William J Jusko; Johannes Schropp
Journal:  J Pharmacokinet Pharmacodyn       Date:  2017-01-10       Impact factor: 2.745

4.  Correction to: Pharmacokinetics of Fentanyl and Its Derivatives in Children: A Comprehensive Review.

Authors:  Victoria C Ziesenitz; Janelle D Vaughns; Gilbert Koch; Gerd Mikus; Johannes N van den Anker
Journal:  Clin Pharmacokinet       Date:  2018-03       Impact factor: 6.447

5.  Feasibility of Exposure-Response Analyses for Clinical Dose-Ranging Studies of Drug Combinations.

Authors:  Theodoros Papathanasiou; Anders Strathe; Andrew C Hooker; Trine Meldgaard Lund; Rune Viig Overgaard
Journal:  AAPS J       Date:  2018-04-23       Impact factor: 4.009

Review 6.  Pharmacokinetics of Fentanyl and Its Derivatives in Children: A Comprehensive Review.

Authors:  Victoria C Ziesenitz; Janelle D Vaughns; Gilbert Koch; Gerd Mikus; Johannes N van den Anker
Journal:  Clin Pharmacokinet       Date:  2018-02       Impact factor: 6.447

Review 7.  Pharmacodynamic Drug-Drug Interactions.

Authors:  Jin Niu; Robert M Straubinger; Donald E Mager
Journal:  Clin Pharmacol Ther       Date:  2019-04-26       Impact factor: 6.875

8.  Pharmacodynamic Modeling of Cell Cycle Effects for Gemcitabine and Trabectedin Combinations in Pancreatic Cancer Cells.

Authors:  Xin Miao; Gilbert Koch; Sihem Ait-Oudhia; Robert M Straubinger; William J Jusko
Journal:  Front Pharmacol       Date:  2016-11-15       Impact factor: 5.810

9.  Model-Based Evaluation of Radiation and Radiosensitizing Agents in Oncology.

Authors:  Tim Cardilin; Joachim Almquist; Mats Jirstrand; Astrid Zimmermann; Samer El Bawab; Johan Gabrielsson
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2017-12-14

10.  Target-Mediated Drug Disposition Model for Bispecific Antibodies: Properties, Approximation, and Optimal Dosing Strategy.

Authors:  Johannes Schropp; Antari Khot; Dhaval K Shah; Gilbert Koch
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2019-01-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.